(Q50893441)

English

A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients.

scientific article published on 20 June 2013

Statements

A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit